Raj Chovatiya, MD, PhD: Hidradenitis Suppurativa Is the ‘Definition of Unmet Need’
September 17th 2024This Maui Derm NP+PA Fall session discusses the latest advancements in hidradenitis suppurativa treatment, the evolving therapeutic landscape, and the critical need for timely diagnosis and aggressive care.
Infectious Disease and Dermatology Crossover: What Providers Need to Know
September 17th 2024At Maui Derm NP+PA Fall 2024, Ted Rosen, MD, and George Hightower, MD, PhD, review the landscape of infectious diseases that can have dermatologic involvement, including viral, bacterial, fungal, and parasitic illnesses.
Melodie Young, MSN, ANP-c: Key Psoriasis Treatment Advances for Pediatric Patients
September 16th 2024At Maui Derm NP+PA Fall 2024, Melodie Young, MSN, ANP-c, reviews new treatment options for pediatric patients with psoriasis and details the difference in disease manifestation between adults and children.
Pediatric Pearls From the Literature: Highlights From 2023 and 2024
September 16th 2024At Maui Derm NP+PA Fall, Sheila Fallon Friedlander, MD, reviews key findings for the pediatric population from recent dermatology literature, covering topics like cutaneous Crohn’s disease, interrupting the atopic march, advancements in gene therapy, and more.
Patients With Moderate to Severe Alopecia Areata Exhibit Higher Risk of Developing Atopic Dermatitis
July 31st 2024Data from a retrospective analysis demonstrated that patients with moderate to severe alopecia areata are at a higher risk of developing atopic dermatitis compared to those with mild alopecia areata.